{
    "relation": [
        [
            "Company",
            "SYNERGETICS\u2026",
            "VASCULAR SO\u2026",
            "STANCORP FI\u2026",
            "TEEKAY TANK\u2026",
            "NORDIC AMER\u2026"
        ],
        [
            "Symbol",
            "SURG",
            "VASC",
            "SFG",
            "TNK",
            "NAT"
        ],
        [
            "Price",
            "4.63",
            "38.13",
            "113.90",
            "7.49",
            "15.47"
        ],
        [
            "%Chg",
            "+6.93%",
            "+2.12%",
            "+0.40%",
            "0.00",
            "-0.96%"
        ]
    ],
    "pageTitle": "Merck KGaA Enrolls First Patient in Study - March 28, 2014 - Zacks.com",
    "title": "",
    "url": "http://www.zacks.com/stock/news/128056/merck-kgaa-enrolls-first-patient-in-study",
    "hasHeader": true,
    "headerPosition": "FIRST_ROW",
    "tableType": "RELATION",
    "tableNum": 2,
    "s3Link": "common-crawl/crawl-data/CC-MAIN-2015-32/segments/1438042981576.7/warc/CC-MAIN-20150728002301-00136-ip-10-236-191-2.ec2.internal.warc.gz",
    "recordEndOffset": 840396159,
    "recordOffset": 840374863,
    "tableOrientation": "HORIZONTAL",
    "TableContextTimeStampAfterTable": "{21628=Merck Serono\u2019s revenues decreased 0.7% in 2013 due to currency headwinds of 4.6%. Rebif sales grew organically by 1.4% in the year. Gonal-f sales fell organically by 0.7% in 2013 due to an adverse foreign exchange impact of 3.5%., 60538=Copyright \u00a9 2015 Zacks Investment Research, 60599=At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm., 14877=by Zacks Equity Research \u00a0\u00a0Published on March 28, 2014 |}",
    "lastModified": "Tue, 28 Jul 2015 01:22:29 -0500",
    "textBeforeTable": "Income Momentum Value Growth Zacks #1 Rank Top Movers for Jul 28, 2015 Zacks #1 Rank Top Movers Zacks #1 Rank Top Movers for 07/28/15 } } document.getElementById('score_val').className = ''; document.getElementById('score_val').innerHTML = ''; document.getElementById('tab_label').innerHTML = tab_text; { else } document.getElementById('score_val').className = 'scores_val'; document.getElementById('score_val').innerHTML = 'A'; document.getElementById('tab_label').innerHTML = tab_text+ ' Score'; { if(tab_text != 'income') document.getElementById('rank_text').innerHTML = cat_uri; var cat_uri = 'View All Zacks Rank #1 '+tab_text+' Stocks'; var cat_uri = '/stocks/buy-list/'+tab_text; { function footer_text(tab_text)",
    "textAfterTable": "Company Symbol Price %Chg TRINITY IND\u2026 TRN 28.31 +3.59% TESSCO TECH\u2026 TESS 23.42 +2.90% ITT EDUCATI\u2026 ESI 4.90 +2.73% GUESS? INC GES 22.06 +2.37% ULTRA CLEAN\u2026 UCTT 7.22 +2.12% Company Symbol Price %Chg SYNERGETICS\u2026 SURG 4.63 +6.93% VASCULAR SO\u2026 VASC 38.13 +2.12% STANCORP FI\u2026 SFG 113.90 +0.40% TEEKAY TANK\u2026 TNK 7.49 0.00",
    "hasKeyColumn": true,
    "keyColumnIndex": 0,
    "headerRowIndex": 0
}